does tirzepatide help with autoimmune disease Do Anti-Obesity Medications Benefit Diseases? Using GLP-1 Agonists with Biologics

Biomed J Sci & Tech Res 49(1)-2023

The Advertising Standards Authority (ASA) has ruled against several weight loss patches making unsubstantiated claims, including rulings against slimming patches in 2020, 2022, and 2023

Exendin 939 did not affect proton-induced TRPV1 activation, suggesting its selective antagonism

A., Damstra, R

Furthermore, a retrospective analysis of a Chinese cohort of knee OA patients with type 2 diabetes, those patients who had been prescribed a GLP-1 agonist (including liraglutide, semaglutide or other), exhibited reduced cartilage volume loss after 2 years, compared to those patients who had not been prescribed a GLP-1 agonist [78]